Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort

Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort

Abstract Introduction Vaccination plays a fundamental role in mastering the COVID‐19 pandemic and protecting vulnerable groups. Persons with autoimmune inflammatory rheumatic diseases (AIIRD) requiring immunosuppressive therapies are prioritized for vaccination. However, data concerning immunogenici...

Full description

Bibliographic Details
Main Authors: Batool Zamani, Amin Moradi Hasan‐Abad, Ahmad Piroozmand, Mahsa Dehghani, Maryam Arfaatabar, Hossein Motedayyen
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Immunity, Inflammation and Disease
Subjects:
adverse events
BBIBP‐CorV vaccine
disease activity
immunogenicity
patients with AIIRD
Online Access:https://doi.org/10.1002/iid3.858

Internet

https://doi.org/10.1002/iid3.858

Similar Items